ConductScience.org, home

Paper2339729

Interstitial radiotherapy for the treatment of advanced or recurrent vulvar and distal vaginal malignancy.

Hoffman M and 7 others. Am J Obstet Gynecol, 1990. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Interstitial radiotherapy for the treatment of advanced or recurrent vulvar and distal vaginal malignancy. Papers, record 2339729. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2339729

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interstitial radiotherapy for the treatment of advanced or recurrent vulvar and distal vaginal malignancy.
PubMed
Journal
Am J Obstet Gynecol
PubMed
Year
1990
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
1.71
iCite
Revised in PubMed
2019-06-15
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hoffman MM
2Greenberg SS
3Greenberg HH
4Fiorica JVJ V
5Roberts WSW S
6LaPolla JPJ P
7Noriega BKB K
8Cavanagh DD

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BrachytherapyMajor topic
Neoplasm Recurrence, LocalMajor topic
Vaginal NeoplasmsMajor topic
Vulvar NeoplasmsMajor topic
Adult
Aged
Aged, 80 and over
Carcinoma, Squamous Cell
Combined Modality Therapy
Female
Humans
Middle Aged
Necrosis
Perineum
Radiation Injuries
Radioisotope Teletherapy
Radiotherapy Dosage

Source PubMed

Download CSV of topics

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
39748686Postoperative radiotherapy in the management of vulvar cancer.Tunis Med2024https://conductscience.org/library/papers/39748686PubMed
33431443Multidisciplinary management of patients with pubic osteomyelitis, a rare but serious complication after surgery and radiation therapy for advanced gynaecological cancer.BMJ Case Rep2021https://conductscience.org/library/papers/33431443PubMed
28979888High-Dose Rate Salvage Interstitial Brachytherapy: A Case-Based Guide to the Treatment of Therapeutically Challenging Recurrent Vulvar Cancer.Front Oncol2017https://conductscience.org/library/papers/28979888PubMed
12057077Recurrent vulvar cancer.Curr Treat Options Oncol2002https://conductscience.org/library/papers/12057077PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2339729

GET https://conductscience.org/api/papers/v1/2339729/authors